Results From the CheckMate 143 Clinical Trial
Author:
Affiliation:
1. Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles
Publisher
American Medical Association (AMA)
Subject
Oncology,Cancer Research
Link
https://jamanetwork.com/journals/jamaoncology/articlepdf/2766209/jamaoncology_muftuoglu_2020_ed_200003.pdf
Reference15 articles.
1. Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial;Reardon;JAMA Oncol
2. Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143.;Omuro;Neuro Oncol,2018
3. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.;Okada;Lancet Oncol,2015
4. First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.;Liau;J Transl Med,2018
5. Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation.;McDonald;Oncol Lett,2015
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Classical Monocytes Shuttling for Precise Delivery of Nanotherapeutics to Glioblastoma;Advanced Healthcare Materials;2024-08-30
2. Evaluation of the Immunomodulatory Effects of Radiation for Chimeric Antigen Receptor T Cell Therapy in Glioblastoma Multiforme;Cells;2024-06-21
3. Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification;Aging;2024-04-12
4. CTLA-4 blockade induces a microglia-Th1 cell partnership that stimulates microglia phagocytosis and anti-tumor function in glioblastoma;Immunity;2023-09
5. The Efficacy of Pretreatment 18F-FDG PET-CT-Based Deep Learning Network Structure to Predict Survival in Nasopharyngeal Carcinoma;Clinical Medicine Insights: Oncology;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3